The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.

Clinical Studies

Over 100 independent peer-reviewed publications and abstracts presented at scientific conferences, authored by nearly 30 different investigators, have featured FIRM-guided therapy as an atrial fibrillation treatment (AF or Afib). This section provides summaries of significant studies featuring the Topera® Rotor Mapping Solution. None of these studies were funded by Topera, now Abbott Electrophysiology.

The complication rate reported for FIRM-guided procedures is comparable to the complication rate for non-FIRM-guided procedures. Additional information is available in the publications. As is the case with any interventional procedure, FIRM-guided procedures are not without risk. Discuss the risks and benefits with your physician to determine what is right for you.

Read peer-reviewed publications that feature FIRM-guided therapy

Read presentations and other publications that feature FIRM-guided therapy

Review all aspects of published studies to be fully informed as to the strengths and weaknesses of any particular study.

Copies of published articles and RhythmView® labeling are available on request. Any questions regarding the publications or clinical use of RhythmView Workstation should be directed to our medical affairs team.

If you have questions about the clinical studies shared on our bibliography page or would like to discuss the studies in more detail, please contact our medical affairs team.

We make every effort to update this section as new studies are published featuring FIRM-guided therapy; however, this may not reflect the most recent publications. If you would like to add a study to our bibliography page that you do not see on our list, please contact our medical affairs team with the name of the publication, abstract or presentation you would like to suggest.